Related Experiment Video
Updated: May 18, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Primary prevention of heart failure
1Emory University, Atlanta, GA 30322, USA.
ISRN Cardiology
|September 8, 2012
Summary
Primary prevention of heart failure is critically needed. Current research focuses on treatment, unlike coronary disease, necessitating a shift towards preventing heart failure before it manifests.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Heart failure research predominantly targets treatment and secondary prevention in diagnosed patients.
- Coronary artery disease research has prioritized primary prevention for over 30 years.
- The epidemiology of heart failure is worsening, highlighting an urgent need for proactive strategies.
Purpose of the Study:
- To emphasize the critical need for a primary prevention focus in heart failure research and quality improvement.
- To draw a parallel with the successful primary prevention efforts in coronary artery disease.
- To advocate for a shift in research and clinical practice towards preventing heart failure onset.
Main Methods:
- This study is a perspective/review based on current literature and epidemiological trends.
- It analyzes the disparity in prevention focus between heart failure and coronary artery disease.
- It synthesizes arguments for prioritizing primary prevention in heart failure.
Main Results:
- Current quality improvement and research efforts in heart failure are heavily skewed towards post-diagnosis management.
- A significant gap exists in primary prevention strategies for heart failure compared to coronary artery disease.
- The projected increase in heart failure cases underscores the inadequacy of the current approach.
Conclusions:
- A paradigm shift towards primary prevention of heart failure is urgently required.
- Implementing primary prevention strategies could mitigate the growing burden of heart failure.
- Increased focus on primary prevention will improve long-term cardiovascular health outcomes.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.